(Q44217981)

30 November 2017

title

Use of propranolol to reduce the rebleeding rate during injection sclerotherapy prior to variceal obliteration (English)

1 reference

30 November 2017

Westaby D

1

1 reference

30 November 2017

Melia W

2

1 reference

30 November 2017

Hegarty J

3

1 reference

30 November 2017

Gimson AE

4

1 reference

30 November 2017

Stellon AJ

5

1 reference

30 November 2017

Williams R

6

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 July 1986

1 reference

30 November 2017

1 reference

30 November 2017

volume

6

1 reference

30 November 2017

issue

4

1 reference

30 November 2017

page(s)

673-675

1 reference

Acute tuberculous abscess of the thyroid gland.

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Acute bleeding varices: a five-year prospective evaluation of tamponade and sclerotherapy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Failure of repeated injection sclerotherapy to improve long-term survival after oesophageal variceal bleeding. A five-year prospective controlled clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Sclerotherapy after first variceal hemorrhage in cirrhosis. A randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

A Prospective Randomized Study of Two Sclerotherapy Techniques for Esophageal Varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Injection sclerotherapy for oesophageal varices: a prospective randomised trial of different treatment schedules

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Comparison of three adrenoreceptor blocking agents in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Selective and non-selective beta receptor blockade in the reduction of portal pressure in patients with cirrhosis and portal hypertension

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Controlled Trial of Propranolol for the Prevention of Recurrent Variceal Hemorrhage in Patients with Cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

B1 selective adrenoreceptor blockade for the long term management of variceal bleeding. A prospective randomised trial to compare oral metoprolol with injection sclerotherapy in cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840060422

7 January 2021

Identifiers

DOI

10.1002/HEP.1840060422

1 reference

30 November 2017

1 reference